Search

everythinglearnresearchcommunity

for

Search:↓

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Effective treatments for severe alopecia areata are still lacking.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Nitrogen mustard was not very effective for hair regrowth in alopecia areata and has potential skin cancer risk.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Hair loss from alopecia areata can rarely be caused by dental problems, and treating the dental issue may reverse the hair loss.

The treatment for alopecia areata with diphenylcyclopropenone was unsuccessful.

Topical minoxidil can help hair regrowth in alopecia areata patients, but maintaining the growth after stopping treatment is inconsistent.

Zinc supplementation may be an important part of treating severe hair loss.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Certain blood miRNAs are linked to severe alopecia areata and could lead to new treatments.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Wigs significantly improve the well-being of people with severe hair loss.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Multiple courses of pulse corticosteroid therapy improve hair growth in alopecia areata patients with minimal side effects.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

Platelet rich plasma is as effective as triamcinolone for treating alopecia areata.

Topical immunotherapy is the best treatment for severe alopecia areata.

Platelet-Rich Plasma treatment has limited and temporary effects on severe Alopecia Areata and does not prevent relapses.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

Liquid nitrogen cryotherapy and betamethasone lotion are equally effective for treating alopecia areata.